I predict that the number of early adopters of a newly released covid vaccine is likely going to be very low (i.e. compared to take-up rate for an annual flu va

I predict that the number of early adopters of a newly released covid vaccine is likely going to be very low (i.e. compared to take-up rate for an annual flu vaccine) due to perceived risk of rushing the trials and production. So I suppose the lower threshold is a good thing.